Related Experiment Video
Updated: Aug 15, 2026

Subcutaneous Angiotensin II Infusion using Osmotic Pumps Induces Aortic Aneurysms in Mice
Published on: September 28, 2015
Role of angiotensin II in experimental membranous nephropathy
F B Gabbai1, C B Wilson, R C Blantz
1Veterans Administration Medical Center, La Jolla, California.
Abstract:
Glomerular hemodynamics measurements in rats with experimental membranous nephropathy [passive Heymann nephritis (PHN)] have demonstrated that the appearance of proteinuria 5 days after administration of anti-Fx1A antibody is temporally related to changes in the glomerular ultrafiltration coefficient (LpA). Previous studies in other models of glomerular injury have suggested a significant role for angiotensin II (ANG II) in the glomerular hemodynamic abnormalities. To evaluate the possible role of ANG II in the LpA decrease, converting enzyme inhibitor (CEI) was administered acutely or chronically (5 days before and after induction of PHN) to rats with PHN. Acute ANG II blockade produced a fall in mean arterial pressure (MAP), single-nephron glomerular filtration rate (SNGFR), absolute proximal reabsorption (APR), single-nephron plasma flow, single-nephron blood flow, and glomerular capillary hydrostatic pressure (PG); however, no changes in LpA were detected. Chronic administration of CEI (MK421, 5 mg.kg-1.day-1) in the drinking water was associated with a fall in MAP; however, both SNGFR and APR increased. PG and the transcapillary hydrostatic pressure gradient were unchanged, and LpA remained depressed. These results suggest that reduction of LpA in rats with PHN is ANG II independent and that other mechanisms are required to explain these changes in glomerular hemodynamics.
Insights
Angiotensin II (ANG II) does not cause reduced glomerular ultrafiltration coefficient (LpA) in passive Heymann nephritis (PHN). This study indicates ANG II-independent mechanisms are responsible for hemodynamic changes in this model of kidney injury.
Area of Science:
- Nephrology
- Renal Physiology
- Experimental Medicine
Background:
- Proteinuria in passive Heymann nephritis (PHN) correlates with altered glomerular ultrafiltration coefficient (LpA).
- Angiotensin II (ANG II) is implicated in glomerular hemodynamic changes in other kidney injury models.
Purpose of the Study:
- To investigate the role of ANG II in the reduction of LpA during experimental membranous nephropathy (PHN).
Main Methods:
- Rats with PHN were treated with a converting enzyme inhibitor (CEI) either acutely or chronically.
- Measurements included mean arterial pressure (MAP), single-nephron glomerular filtration rate (SNGFR), absolute proximal reabsorption (APR), and glomerular capillary hydrostatic pressure (PG).
Main Results:
- Acute CEI administration lowered MAP, SNGFR, APR, and PG but did not alter LpA.
- Chronic CEI treatment decreased MAP but increased SNGFR and APR, with unchanged PG and persistently depressed LpA.
Conclusions:
- The reduction in LpA observed in PHN is independent of Angiotensin II.
- Other mechanisms, not involving ANG II, mediate the observed changes in glomerular hemodynamics in this model of membranous nephropathy.
More Related Videos
Related Concept Videos
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Heart Failure II: Pathophysiology
Nephrotic Syndrome II : Assessment and Medical Management
Acute Kidney Injury II: Pathophysiology
Diabetic Nephropathy

